«上一篇/Previous Article|本期目录/Table of Contents|下一篇/Next Article»

《天津医科大学学报》[ISSN:1006-8147/CN:12-1259/R]

卷:

27卷

期数:

2021年02期

页码:

127-132

栏目:

临床医学

出版日期:

2021-03-15

文章信息/Info

Title:

Analysis, screening and validation of diagnostic or prognostic markers for prostate cancer based on TCGA database

文章编号:

1006-8147（2021）02-0127-06

作者:

贺倩¹; 王亮²; 门剑龙³

（天津医科大学总医院1.医学检验科；2.泌尿外科；3.精准医学中心，天津 300052）

Author(s):

HE Qian¹; WANG Liang²; MEN Jian-long³

（1.Department of Medicine Laboratory；2.Department of Urology；3.Precision Medicine Center，General Hospital，Tianjin Medical University，Tianjin 300052，China)

关键词:

前列腺癌; 表达谱; DNA甲基化; SRSF5

Keywords:

prostate cancer; expression profile; DNA methylation; SRSF5

分类号:

R737.25

DOI:

-

文献标志码:

A

摘要:

目的：综合分析表达谱数据与DNA甲基化数据，探索新的前列腺癌诊断或预后的标志物。方法：在TCGA公共数据库下载前列腺癌的甲基化水平数据以及mRNA表达数据；利用R软件中的DESeq2包对表达谱数据进行差异表达分析，利用R软件中的limma包对DNA甲基化芯片进行差异甲基化位点分析；采用美国国立卫生研究院的DAVID v6.7在线软件平台进行功能和通路的富集分析；对筛选出的基因进行Kaplan-Meier生存分析以及分子生物学实验验证。结果：差异表达分析得到1 130个差异表达基因，其中759个表达下调，371个表达上调；差异甲基化位点分析获得375个差异甲基化位点，其中8个低甲基化位点，367个高甲基化位点；综合分析发现CBX5、NBPF13P、RARB、RCN1、SRSF5基因的异常甲基化与肿瘤复发风险密切相关；定量PCR显示前列腺癌患者SRSF5 mRNA水平升高（P<0.05），甲基化特异性PCR显示前列腺癌患者SRSF5甲基化水平降低（均P<0.05）。结论：SRSF5在前列腺癌患者中甲基化水平降低且mRNA表达水平升高，且其低甲基化水平与复发风险密切相关。

Abstract:

Objective: To comprehensively analyze the expression profile data and DNA methylation data in order to explore new molecular targets or potential therapeutic targets for prostate cancer. Methods: The methylation data and mRNA expression data of prostate cancer from TCGA public database were downloaded. Differential expression analysis was performed using DESeq2 package in R software and differential methylation site analysis was performed using limma package in R software. Then，enrichment analysis of functions and pathways were performed using the DAVID v6.7 online software platform. Finally，Kaplan-Meier survival analysis and molecular biological experiments were performed on the selected genes. Results: Differential expression analysis revealed 1 130 differentially expressed genes，of which 759 were down-regulated and 371 were up-regulated. Differential methylation sites analysis obtained 375 differential methylation sites，including 8 hypomethylation sites and 367 hypermethylation sites. Comprehensive analysis found that abnormal methylation of CBX5，NBPF13P，RARB，RCN1，and SRSF5 genes were closely related to the risk of recurrence. Quantitative PCR showed that SRSF5 mRNA were increased（all P<0.05）， and methylation-specific PCR successfully showed that the methylation was decreaed in patients with prostate cancer. Conclusion: The methylation level of SRSF5 is decreased and mRNA expression level is increased in patients with prostate cancer，and its low methylation level is closely related to the risk of recurrence.

参考文献/References:

[1] Zhao S G，Chen W S，Li H，et al. The DNA methylation landscape of advanced prostate cancer[J]. Nat Genet，2020，52（8）：778
[2] Siegiel R，Miller K，Jemal A. Cancer statistics，2017[J]. CA Cancer J Clin，2017，67：7
[3] Siegel Rebecca L，Miller Kimberly D，Jemal A. Cancer statistics，2018[J]. CA Cancer J Clin，2018，68（1）：7
[4] Berhaupt-Glickstein A，Hooker N H，Hallman W K. Qualified health claim language affects purchase intentions for green tea products in the United States[J]. Nutrients，2019，11（4）：921
[5] Klotz L，Zhang L，Lam A，et al. Clinical results of long-term follow-up of a large，active surveillance cohort with localized prostate cancer[J]. J Clin Oncol，2009，28（1）：126
[6] Singal R，Ferdinand L，Reis I M，et al. Methylation of multiple genes in prostate cancer and the relationship with clinicopathological features of disease[J]. Oncol Rep，2004，12（3）：631
[7] Tang D，Kryvenko O N，Mitrache N，et al. Methylation of the RARB gene increases prostate cancer risk in black Americans[J]. J Urol，2013，190（1）：317
[8] Xu S，Xu Y，Chen L，et al. RCN1 suppresses ER stress-induced apoptosis via calcium homeostasis and PERK-CHOP signaling[J]. Oncogenesis，2017，6（3）：e304
[9] Liu X，Zhang N，Wang D，et al. Downregulation of reticulocalbin-1 differentially facilitates apoptosis and necroptosis in human prostate cancer cells[J]. Cancer Sci，2018，109（4）：1147
[10] Kuhn B M，Nodzyński T，Errafi S，et al. Flavonol-induced changes in PIN2 polarity and auxin transport in the Arabidopsis thaliana rol1-2 mutant require phosphatase activity[J]. Sci Rep，2017，7（1）：1
[11] Chen X，Shao W，Huang H，et al. Overexpression of RCN1 correlates with poor prognosis and progression in non-small cell lung cancer[J]. Hum Pathol，2019，83：140
[12] Wang G，Wang Q，Fan Y，et al. Reticulocalbin 2 correlates with recurrence and prognosis in colorectal cancer[J]. Am J Cancer Res，2017，7（11）：2169
[13] Wu H，Dai Y，Zhang D，et al. LINC00961 inhibits the migration and invasion of colon cancer cells by sponging miR-223-3p and targeting SOX11[J]. Cancer Med，2020，9（7）：2514
[14] Lin S，Choe J，Du P，et al. The m6A methyltransferase METTL3 promotes translation in human cancer cells[J]. Mol Cell，2016，62（3）：335
[15] Chen Y，Huang Q，Liu W，et al. Mutually exclusive acetylation and ubiquitylation of the splicing factor SRSF5 control tumor growth[J]. Nat Commun，2018，9（1）：2464
[16] Kim H R，Lee G O，Choi K H，et al. SRSF5：a novel marker for small-cell lung cancer and pleural metastatic cancer[J]. Lung Cancer，2016，99：57
[17] Yan J，Zhang D，Han Y，et al. Antitumor activity of SR splicing-factor 5 knockdown by downregulating pyruvate kinase M2 in non-small cell lung cancer cells[J]. J Cell Biochem，2019，120（10）：17303
[18] Yang S，Jia R，Bian Z. SRSF5 functions as a novel oncogenic splicing factor and is upregulated by oncogene SRSF3 in oral squamous cell carcinoma[J]. Mol Cell Res，2018，1865（9）：1161
[19] Zhou L，Guo J，Jia R. Oncogene SRSF3 suppresses autophagy via inhibiting BECN1 expression[J]. Biochem Bioph Res Co，2019，509（4）：966
[20] Gautrey H L，Tyson-Capper A J. Regulation of Mcl-1 by SRSF1 and SRSF5 in cancer cells[J]. PloS One，2012，7（12）：e51497
[21] Tyson-Capper A，Gautrey H. Regulation of Mcl-1 alternative splicing by hnRNP F，H1 and K in breast cancer cells[J]. RNA Biol，2018，15（12）：1448
[22] Condon J C，Kyathanahalli C，Anamthathmakula P，et al. Estrogen/estrogen receptor action and the pregnant myometrium[J]. Curr OpinPhysiol，2020，13：135

相似文献/References:

[1]魏强,齐灿,罗飞,等.转移性去势抵抗性前列腺癌患者多西他赛化疗的预后分析[J].天津医科大学学报,2013,19(05):390.
[2]杨帮东,姜行康,齐 灿,等.尿液中PCA3评分对前列腺癌早期诊断的临床意义[J].天津医科大学学报,2013,19(06):487.
　YANG Bang-dong,JIANG Xing-kang,QI Can,et al.Clinical significance of urinary PCA3 score to diagnose prostate cancer[J].Journal of Tianjin Medical University,2013,19(02):487.
[3]刘利维,刘春雨. MicroRNAs 与前列腺癌的表观遗传学研究进展[J].天津医科大学学报,2014,20(01):74.
[4]王 超,余泉峰,徐 勇,等.经直肠超声造影诊断前列腺癌的临床分析[J].天津医科大学学报,2014,20(05):375.
　WANG Chao,YU Quan-feng,XU Yong,et al.Clinical analysis of contrast-enhanced transrectal ultrasonography for the diagnosis of prostate cancer[J].Journal of Tianjin Medical University,2014,20(02):375.
[5]张晓会,张志宏,徐 勇,等.合并症对局限性或局部晚期前列腺癌患者早期生存的影响[J].天津医科大学学报,2014,20(05):379.
　ZHANG Xiao-hui,ZHANG Zhi-hong,XU Yong,et al. Influence of complications on early survival of patients with localized or locally advanced prostate cancer[J].Journal of Tianjin Medical University,2014,20(02):379.
[6]盛 镔,张 蒙,马鹏德,等.核糖体蛋白L37在前列腺癌中的表达及临床意义[J].天津医科大学学报,2015,21(05):401.
　SHENG Bin,ZHANG Meng,MA Peng-de,et al.Expression of ribosomal protein L37 in prostate cancer and its clinical significance[J].Journal of Tianjin Medical University,2015,21(02):401.
[7]管明秀,周云丽,王 萌,等.TuM2-PK，tPSA，fPSA/tPSA和PSAD对PSA灰区前列腺癌诊断价值的比较[J].天津医科大学学报,2016,22(02):140.
　GUAN Ming-xiu,ZHOU Yun-li,WANG-Meng,et al.Diagnostic implication of TuM2-PK, tPSA, fPSA/tPSA ratio and PSAD for prostate cancer in PSA gray area[J].Journal of Tianjin Medical University,2016,22(02):140.
[8]李 江,张恩龙,赵 阳,等.前列腺癌靶向磁共振成像和光热治疗的实验研究[J].天津医科大学学报,2017,23(02):93.
　LI Jiang,ZHANG En-long,ZHAO Yang,et al.?Experimental research of targeted magnetic resonance imaging and photo thermal therapy for prostate cancer [J].Journal of Tianjin Medical University,2017,23(02):93.
[9]张一然,潘盼,连振鹏,等.磁共振扫描对经直肠超声引导前列腺穿刺活检的影响[J].天津医科大学学报,2017,23(02):99.
　ZHANG Yi-ran,PAN Pan,LIAN Zhen-peng,et al.Effect of magnetic resonance imaging scan on the?transrectal ultrasound?prostate biopsy[J].Journal of Tianjin Medical University,2017,23(02):99.
[10]薄志强,孙桂江,王 丽,等.CtBP2异常表达对前列腺癌PC3细胞增殖效应影响的研究[J].天津医科大学学报,2017,23(02):103.
　BO Zhi-qiang,SUNGui-jiang,WANG Li,et al.Effect of abnormal expression of CtBP2 on the proliferation of prostate cancer cell line PC3[J].Journal of Tianjin Medical University,2017,23(02):103.

备注/Memo

备注/Memo:

作者简介 贺倩（1981-），女，学士，主管技师，研究方向：生化免疫检验；通信作者：门剑龙，E-mail:thromhaemo@126.com。

常用功能

更新日期/Last Update: 2021-03-10